Matches in SemOpenAlex for { <https://semopenalex.org/work/W1489201912> ?p ?o ?g. }
- W1489201912 endingPage "790" @default.
- W1489201912 startingPage "790" @default.
- W1489201912 abstract "The US veteran population represents a unique cohort of patients in whom human papillomavirus (HPV)-related head and neck squamous cell carcinoma (HNSCC) has yet to be investigated.To investigate the incidence and characteristics of HPV-positive HNSCC within the veteran population.Retrospective medical record review including patients with HNSCC diagnosed between January 1, 2010, and November 15, 2013, from the VA Greater Los Angeles Healthcare System. Data were collected between November 16, 2013, and June 19, 2014, and analyzed between June 20, 2014, and March 26, 2015.Chemoradiation therapy, radiation therapy, surgery, or no treatment.We determined HPV positivity by p16 testing. Demographic and clinicopathologic information and overall survival were extracted from medical records.We identified 150 patients with the diagnosis of HNSCC. Sixty-nine patients had HPV-positive tumors (46%), and 65 (43%) had HPV-negative tumors (16 did not have HPV testing). Age at diagnosis ranged from 44 to 94 years (mean, 64.6 [SD, 8.0] years), and median (interquartile range) follow-up was 16.7 (8.7-27.3) years. Tumor location differed significantly between the 2 groups, with an HPV-positive predominance in the oropharynx (43 of 57 [75%]; P < .001). The HPV-positive patients were more likely to be treated primarily with combined chemoradiation therapy than radiation therapy or surgery (P < .001). T4 tumors had a nearly 9 times greater rate of mortality compared with T1 tumors (HR, 8.52 [95% CI, 2.60-18.40; P < .001); N3 disease was associated with 7.18 times greater mortality (HR, 7.18 [95% CI, 1.99-12.26]; P < .001) compared with N1 disease; and M1 disease was associated with 6.0 times greater mortality (HR, 5.99 [95% CI, 2.59-13.81]; P < .001). There were 42 total deaths during follow-up, 25 in the HPV-negative group and 17 in the HPV-positive group, with a nonsignificantly higher overall survival among HPV-positive patients independent of alcohol or tobacco use history (P = .09).Previous studies have found that the proportion of HPV-positive HNSCC in the general population ranges between 20% and 75%. Although the incidence of HPV-positive HNSCC in the Veterans Affairs population is comparable, these patients have unique risk factors and demographic characteristics that may suggest different prognostic factors for HPV-positive HNSCC in this population. Nonetheless, HPV-positive tumors still seem to portend a better overall prognosis regardless of alcohol or tobacco history among the Veterans Affairs population." @default.
- W1489201912 created "2016-06-24" @default.
- W1489201912 creator A5039409527 @default.
- W1489201912 creator A5052691269 @default.
- W1489201912 creator A5078534826 @default.
- W1489201912 creator A5079074828 @default.
- W1489201912 date "2015-09-01" @default.
- W1489201912 modified "2023-09-26" @default.
- W1489201912 title "Characteristics of Human Papillomavirus–Associated Head and Neck Cancers in a Veteran Population" @default.
- W1489201912 cites W1492023599 @default.
- W1489201912 cites W1520349699 @default.
- W1489201912 cites W1605134927 @default.
- W1489201912 cites W1968675934 @default.
- W1489201912 cites W1980535334 @default.
- W1489201912 cites W1981663682 @default.
- W1489201912 cites W1984021935 @default.
- W1489201912 cites W1993044734 @default.
- W1489201912 cites W1998694233 @default.
- W1489201912 cites W2014201296 @default.
- W1489201912 cites W2026143423 @default.
- W1489201912 cites W2026161963 @default.
- W1489201912 cites W2026733701 @default.
- W1489201912 cites W2067202506 @default.
- W1489201912 cites W2069913533 @default.
- W1489201912 cites W2070274302 @default.
- W1489201912 cites W2072004105 @default.
- W1489201912 cites W2077191372 @default.
- W1489201912 cites W2104459538 @default.
- W1489201912 cites W2105095480 @default.
- W1489201912 cites W2110664940 @default.
- W1489201912 cites W2112131841 @default.
- W1489201912 cites W2117781588 @default.
- W1489201912 cites W2118441422 @default.
- W1489201912 cites W2123526038 @default.
- W1489201912 cites W2127469674 @default.
- W1489201912 cites W2127605299 @default.
- W1489201912 cites W2128428788 @default.
- W1489201912 cites W2131971625 @default.
- W1489201912 cites W2132239791 @default.
- W1489201912 cites W2133183695 @default.
- W1489201912 cites W2137261097 @default.
- W1489201912 cites W2138271749 @default.
- W1489201912 cites W2139766596 @default.
- W1489201912 cites W2141024484 @default.
- W1489201912 cites W2141274038 @default.
- W1489201912 cites W2143680521 @default.
- W1489201912 cites W2149166037 @default.
- W1489201912 cites W2161649815 @default.
- W1489201912 cites W2164400197 @default.
- W1489201912 cites W2165279145 @default.
- W1489201912 cites W2168315952 @default.
- W1489201912 cites W2170019502 @default.
- W1489201912 cites W2406213538 @default.
- W1489201912 cites W2886259079 @default.
- W1489201912 doi "https://doi.org/10.1001/jamaoto.2015.1447" @default.
- W1489201912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26270931" @default.
- W1489201912 hasPublicationYear "2015" @default.
- W1489201912 type Work @default.
- W1489201912 sameAs 1489201912 @default.
- W1489201912 citedByCount "13" @default.
- W1489201912 countsByYear W14892019122016 @default.
- W1489201912 countsByYear W14892019122017 @default.
- W1489201912 countsByYear W14892019122019 @default.
- W1489201912 countsByYear W14892019122020 @default.
- W1489201912 countsByYear W14892019122021 @default.
- W1489201912 countsByYear W14892019122022 @default.
- W1489201912 countsByYear W14892019122023 @default.
- W1489201912 crossrefType "journal-article" @default.
- W1489201912 hasAuthorship W1489201912A5039409527 @default.
- W1489201912 hasAuthorship W1489201912A5052691269 @default.
- W1489201912 hasAuthorship W1489201912A5078534826 @default.
- W1489201912 hasAuthorship W1489201912A5079074828 @default.
- W1489201912 hasConcept C119060515 @default.
- W1489201912 hasConcept C120665830 @default.
- W1489201912 hasConcept C121332964 @default.
- W1489201912 hasConcept C126322002 @default.
- W1489201912 hasConcept C143998085 @default.
- W1489201912 hasConcept C167135981 @default.
- W1489201912 hasConcept C195910791 @default.
- W1489201912 hasConcept C2776530083 @default.
- W1489201912 hasConcept C2776833033 @default.
- W1489201912 hasConcept C2908647359 @default.
- W1489201912 hasConcept C509974204 @default.
- W1489201912 hasConcept C61511704 @default.
- W1489201912 hasConcept C71924100 @default.
- W1489201912 hasConcept C72563966 @default.
- W1489201912 hasConcept C99454951 @default.
- W1489201912 hasConceptScore W1489201912C119060515 @default.
- W1489201912 hasConceptScore W1489201912C120665830 @default.
- W1489201912 hasConceptScore W1489201912C121332964 @default.
- W1489201912 hasConceptScore W1489201912C126322002 @default.
- W1489201912 hasConceptScore W1489201912C143998085 @default.
- W1489201912 hasConceptScore W1489201912C167135981 @default.
- W1489201912 hasConceptScore W1489201912C195910791 @default.
- W1489201912 hasConceptScore W1489201912C2776530083 @default.
- W1489201912 hasConceptScore W1489201912C2776833033 @default.
- W1489201912 hasConceptScore W1489201912C2908647359 @default.
- W1489201912 hasConceptScore W1489201912C509974204 @default.